XOLAIR
- Product NDC
- 50242-040
- 11-digit product format
- 502420040
- Labeler code
- 50242
- Product ID
- 50242-040_e633fdb6-7fbc-4072-93ed-4e30abc6c3a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- omalizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Genentech, Inc.
- Application
- BLA103976
- Marketing category
- BLA
- Marketing start
- 2003-06-20
- Substance
- OMALIZUMAB
- Active strength
- 150 mg/1.2mL
- Pharmacologic classes
- Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- XOLAIR
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OMALIZUMAB | 150 mg/1.2mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2P471X1Z11 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1657209 | Internal RxNorm lookup |
| 1657212 | Internal RxNorm lookup |
| 2058943 | Internal RxNorm lookup |
| 2058946 | Internal RxNorm lookup |
| 2058949 | Internal RxNorm lookup |
| 2058950 | Internal RxNorm lookup |
| 2663917 | Internal RxNorm lookup |
| 2663918 | Internal RxNorm lookup |
| 2663920 | Internal RxNorm lookup |
| 2663923 | Internal RxNorm lookup |
| 2673760 | Internal RxNorm lookup |
| 2673761 | Internal RxNorm lookup |
| 2673762 | Internal RxNorm lookup |
| 2673763 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ecba0c95-af31-4e39-991d-3814ccdaeba6 | Product name | 1 | 20190103 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50242-040-62 | XOLAIR | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 1.2 | 31 | |
| 50242-040-62 | XOLAIR | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 31 | |
| 50242-040-86 | XOLAIR | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 31 | |
| 50242-040-86 | XOLAIR | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 1.2 | 31 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50242-040-62 | EA - Each | 50242-040 | 25962e90-d014-4788-8bec-fef7f17ad706 | 1 | 2012-07-24 |
| 50242-040-86 | EA - Each | 50242-040 | 71b55c53-8382-46b6-ac89-d36861b211e3 | 1 | 2020-03-10 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OMALIZUMAB | ACTIVE INGREDIENT | 2P471X1Z11 | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 5 | |
| OMALIZUMAB | ACTIVE MOIETY | 2P471X1Z11 | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 5 | |
| HISTIDINE | INACTIVE INGREDIENT | 4QD397987E | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 5 | |
| HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE | INACTIVE INGREDIENT | X573657P6P | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 5 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 5 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50242-040 | XOLAIR (OMALIZUMAB) INJECTION, SOLUTION XOLAIR PFS (OMALIZUMAB) INJECTION, SOLUTION XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 28 | Current NDC, Legacy NDC, 4 package rows | 20241123_7f6a2191-adfb-48b9-9bfa-0d9920479f0d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XOLAIR | OMALIZUMAB | Genentech, Inc. | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | BLA103976 50242-040 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103976 | Xolair | omalizumab | 351(a) | Rx | 2026-06-01 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2673760 | omalizumab 150 MG in 1 ML Auto-Injector | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058943 | omalizumab 150 MG in 1 ML Prefilled Syringe | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 1657209 | omalizumab 150 MG Injection | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663920 | omalizumab 300 MG in 2 ML Auto-Injector | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663917 | omalizumab 300 MG in 2 ML Prefilled Syringe | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673762 | omalizumab 75 MG in 0.5 ML Auto-Injector | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058949 | omalizumab 75 MG in 0.5 ML Prefilled Syringe | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673761 | Xolair 150 MG in 1 ML Auto-Injector | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058946 | Xolair 150 MG in 1 ML Prefilled Syringe | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 1657212 | Xolair 150 MG Injection | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663923 | Xolair 300 MG in 2 ML Auto-Injector | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663918 | Xolair 300 MG in 2 ML Prefilled Syringe | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673763 | Xolair 75 MG in 0.5 ML Auto-Injector | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058950 | Xolair 75 MG in 0.5 ML Prefilled Syringe | PSN | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673763 | 0.5 ML omalizumab 150 MG/ML Auto-Injector [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058950 | 0.5 ML omalizumab 150 MG/ML Prefilled Syringe [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673761 | 1 ML omalizumab 150 MG/ML Auto-Injector [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058946 | 1 ML omalizumab 150 MG/ML Prefilled Syringe [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663923 | 2 ML omalizumab 150 MG/ML Auto-Injector [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663918 | 2 ML omalizumab 150 MG/ML Prefilled Syringe [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 1657212 | omalizumab 150 MG Injection [Xolair] | SBD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673762 | 0.5 ML omalizumab 150 MG/ML Auto-Injector | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058949 | 0.5 ML omalizumab 150 MG/ML Prefilled Syringe | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673760 | 1 ML omalizumab 150 MG/ML Auto-Injector | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058943 | 1 ML omalizumab 150 MG/ML Prefilled Syringe | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663920 | 2 ML omalizumab 150 MG/ML Auto-Injector | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663917 | 2 ML omalizumab 150 MG/ML Prefilled Syringe | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 1657209 | omalizumab 150 MG Injection | SCD | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058950 | 0.5 ML Xolair 150 MG/ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058946 | 1 ML Xolair 150 MG/ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673760 | omalizumab 150 MG per 1 ML Auto-Injector | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058943 | omalizumab 150 MG per 1 ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663920 | omalizumab 300 MG per 2 ML Auto-Injector | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663917 | omalizumab 300 MG per 2 ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673762 | omalizumab 75 MG per 0.5 ML Auto-Injector | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058949 | omalizumab 75 MG per 0.5 ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 1657212 | Xolair 150 MG Injection | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673761 | Xolair 150 MG per 1 ML Auto-Injector | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058946 | Xolair 150 MG per 1 ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663923 | Xolair 300 MG per 2 ML Auto-Injector | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2663918 | Xolair 300 MG per 2 ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2673763 | Xolair 75 MG per 0.5 ML Auto-Injector | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
| 2058950 | Xolair 75 MG per 0.5 ML Prefilled Syringe | SY | 7f6a2191-adfb-48b9-9bfa-0d9920479f0d | 31 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50242-040-62 | 50242004062 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1 VIAL, SINGLE-USE | 2003-06-20 | 0000-00-00 | No | No | Current |
| 50242-040-86 | 50242004086 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1 VIAL, SINGLE-USE | 2013-12-20 | 0000-00-00 | Yes | No | Current |